Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme

[1]  L. Teng,et al.  Smart drug delivery systems for precise cancer therapy , 2022, Acta pharmaceutica Sinica. B.

[2]  Yan Yang,et al.  Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy , 2022, Advanced science.

[3]  L. Zitvogel,et al.  Immunogenic cell stress and death , 2022, Nature Immunology.

[4]  Dunwan Zhu,et al.  Programmed polymersomes with spatio-temporal delivery of antigen and dual-adjuvants for efficient dendritic cells-based cancer immunotherapy , 2022, Chinese Chemical Letters.

[5]  Xiaojing Liu,et al.  Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy , 2022, Advanced science.

[6]  Yuanyuan Yang,et al.  Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity. , 2022, ACS nano.

[7]  Dunwan Zhu,et al.  Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle , 2021, Acta pharmaceutica Sinica. B.

[8]  Fuan Wang,et al.  Boosting Cancer Immunotherapy via the Convenient A2AR Inhibition Using a Tunable Nanocatalyst with Light‐Enhanced Activity , 2021, Advanced materials.

[9]  Jinsong Ding,et al.  Anti‐PD‐L1 DNAzyme Loaded Photothermal Mn2+/Fe3+ Hybrid Metal‐Phenolic Networks for Cyclically Amplified Tumor Ferroptosis‐Immunotherapy , 2021, Advanced healthcare materials.

[10]  Zhigang Xu,et al.  Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death , 2021, Chinese Chemical Letters.

[11]  Jie Tan,et al.  Metal-phenolic networks modified polyurethane as periosteum for bone regeneration , 2021, Chinese Chemical Letters.

[12]  Ying Cai,et al.  T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy , 2021, Nature Nanotechnology.

[13]  Zhijun Sun,et al.  Calcium Phosphate‐Reinforced Metal‐Organic Frameworks Regulate Adenosine‐Mediated Immunosuppression , 2021, Advanced materials.

[14]  N. Chandel,et al.  Cancer metabolism: looking forward , 2021, Nature Reviews Cancer.

[15]  F. Di Virgilio,et al.  ATP and cancer immunosurveillance , 2021, The EMBO journal.

[16]  Ming-zhu Jin,et al.  Immunogenic Cell Death-Based Cancer Vaccines , 2021, Frontiers in Immunology.

[17]  A. Rustgi,et al.  Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment. , 2021, Trends in cancer.

[18]  Sixian Liang,et al.  ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling. , 2021, Life sciences.

[19]  Peng Liu,et al.  Metal-phenolic networks for cancer theranostics. , 2021, Biomaterials science.

[20]  Jinsong Ding,et al.  A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances , 2021, Journal of Nanobiotechnology.

[21]  J. Ji,et al.  Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles , 2021, Nature Communications.

[22]  T. Tsuzuki,et al.  Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival , 2021, Cancer Immunology, Immunotherapy.

[23]  Xuesi Chen,et al.  In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy , 2021 .

[24]  Youqing Shen,et al.  Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. , 2020, Biomaterials.

[25]  Meiwan Chen,et al.  Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition , 2020 .

[26]  Q. Wei,et al.  ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway , 2020, OncoTargets and therapy.

[27]  Peng Liu,et al.  Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer. , 2020, ACS applied materials & interfaces.

[28]  Xiang Chen,et al.  Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria , 2020, Allergy.

[29]  L. Buisseret,et al.  The adenosine pathway in immuno-oncology , 2020, Nature Reviews Clinical Oncology.

[30]  Peng Liu,et al.  Co-delivery of Doxorubicin and DNAzyme Using ZnO@polydopamine Core-Shell Nanocomposites for Chemo/Gene/Photothermal Therapy. , 2020, Acta biomaterialia.

[31]  M. Hung,et al.  ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis. , 2020, Cancer cell.

[32]  G. Yegutkin,et al.  Adenosine Metabolism: Emerging Concepts for Cancer Therapy. , 2019, Cancer cell.

[33]  Peng Liu,et al.  Oxygen-self-supplying and HIF-1α inhibiting core-shell nano-system for hypoxia-resistant photodynamic therapy. , 2019, ACS applied materials & interfaces.

[34]  Wenbin Lin,et al.  Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. , 2018, Angewandte Chemie.

[35]  Li Liu,et al.  ATP-Driven Temporal Control over Structure Switching of Polymeric Micelles. , 2018, Biomacromolecules.

[36]  F. Di Virgilio,et al.  Extracellular ATP and P2 purinergic signalling in the tumour microenvironment , 2018, Nature Reviews Cancer.

[37]  L. Emens,et al.  Targeting adenosine for cancer immunotherapy , 2018, Journal of Immunotherapy for Cancer.

[38]  J. Steyaert,et al.  How the Warburg effect supports aggressiveness and drug resistance of cancer cells? , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[39]  G. Beldi,et al.  Mechanisms of ATP Release by Inflammatory Cells , 2018, International journal of molecular sciences.

[40]  Yun Huang,et al.  Elevated Adenosine Induces Placental DNA Hypomethylation Independent of A2B Receptor Signaling in Preeclampsia , 2017, Hypertension.

[41]  Juewen Liu,et al.  Metal Sensing by DNA. , 2017, Chemical reviews.

[42]  S. Loi,et al.  Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy , 2017, The Journal of clinical investigation.

[43]  Juewen Liu,et al.  Theranostic DNAzymes , 2017, Theranostics.

[44]  Rong-Fu Wang,et al.  The distribution and function of human memory T cell subsets in lung cancer , 2017, Immunologic Research.

[45]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[46]  F. Di Virgilio,et al.  Extracellular purines, purinergic receptors and tumor growth , 2016, Oncogene.

[47]  A. Subudhi,et al.  Beneficial Role of Erythrocyte Adenosine A2B Receptor–Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia , 2016, Circulation.

[48]  X. Long,et al.  Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy , 2016, Neurochemical Research.

[49]  Hong Liu,et al.  Beneficial and detrimental role of adenosine signaling in diseases and therapy. , 2015, Journal of applied physiology.

[50]  K. Uzawa,et al.  Adenosine A2b receptor promotes progression of human oral cancer , 2015, BMC Cancer.

[51]  A. Ribas,et al.  Anti-programmed cell death protein-1/ligand-1 therapy in different cancers , 2015, British Journal of Cancer.

[52]  W. Cao,et al.  Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1. , 2014, Frontiers in bioscience.

[53]  Jeffrey A. Wiser,et al.  ImmPort: disseminating data to the public for the future of immunology , 2014, Immunologic Research.

[54]  E. Condom,et al.  High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors , 2014, Mediators of inflammation.

[55]  L. Antonioli,et al.  Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.

[56]  L. Belardinelli,et al.  Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis , 2010, PloS one.

[57]  G. Mutlu,et al.  Adenosine A1 receptor, a target and regulator of ERα action, mediates the proliferative effects of estradiol in breast cancer , 2009, Oncogene.

[58]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[59]  S. Baltacı,et al.  Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. , 2003, European urology.

[60]  H. Gabbert,et al.  Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.